ProPhase Labs, Inc. 13D and 13G filings for Lantern Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | Lantern Pharma Inc. LTRN | ProPhase Labs Inc. PRPH | 631,195 5.800% | -278,805 (-30.64%) | Filing |
| 2022-11-21 4:15 pm Purchase | 2022-11-08 | 13G | Lantern Pharma Inc. LTRN | ProPhase Labs Inc. PRPH | 910,000 8.400% | 910,000 (New Position) | Filing |